Prostate Cancer - Results from #24540

A cohort study reporting clinical risk factors and individual risk perceptions of prostate cancer: Implications for PSA testing - Abstract October 26, 2012

Interactions in the aetiology, presentation and management of synchronous and metachronous adenocarcinoma of the prostate and rectum - Abstract October 26, 2012

African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke Prostate Center - Abstract October 26, 2012

The efficacy of degarelix on LUTS (Lower urinary tract symptoms) relief in patients with  prostate cancer - Abstract October 26, 2012

Response in bone turnover markers during therapy predicts overall survival in patients with metastatic prostate cancer: Analysis of three clinical trials - Abstract October 26, 2012

Detection of prostate cancer by sialic acid level in patients with non-diagnostic levels of prostate-specific antigen - Abstract October 25, 2012

Nuclear Stat5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy - Abstract October 25, 2012

Prostate cancer-from steroid transformations to clinical translation - Abstract October 25, 2012

In-depth investigation of archival and prospectively collected samples reveals no evidence for XMRV infection in prostate cancer - Abstract October 25, 2012

An accurate prostate cancer prognosticator using a seven-gene signature plus Gleason score and taking cell type heterogeneity into account - Abstract October 25, 2012

A multiplex assay to measure RNA transcripts of prostate cancer in urine - Abstract October 25, 2012

Is radical prostatectomy a useful therapeutic option for high-risk prostate cancer in older men? - Abstract October 25, 2012

Radical radiotherapy for high-risk prostate cancer in older men - Abstract October 25, 2012

Advances in the treatment of prostate cancer - dawn of a new era - Abstract October 25, 2012

First web-based prostate cancer database launches to help new patients manage care, avoid complications October 24, 2012

Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence - Abstract October 24, 2012

Contemporary role of systematic prostate biopsies: Indications, techniques, and implications for patient care - Abstract October 24, 2012

Noninvasive assay monitored treatment response in patients with metastatic prostate cancer October 24, 2012

Thromboembolic events following surgery for prostate cancer - Abstract October 24, 2012

The REDUCE Follow-up Study: Low rate of new prostate cancer diagnoses observed during a 2-year, observational, follow-up study of men who participated in the REDUCE (REduction by DUtasteride of prostate Cancer Events) trial - Abstract October 24, 2012

Page 1228 of 1436